Rocket Pharmaceuticals Stock Investor Sentiment
| RCKT Stock | USD 3.45 0.18 4.96% |
Slightly above 67% of Rocket Pharmaceuticals' investor base is looking to short. The analysis of the overall investor sentiment regarding Rocket Pharmaceuticals suggests that many traders are alarmed. Rocket Pharmaceuticals' investing sentiment can be driven by a variety of factors including economic data, Rocket Pharmaceuticals' earnings reports, geopolitical events, and overall market trends.
Comfort Level 33
Alarmed
Panic | Confidence |
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use Rocket Pharmaceuticals' input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward Rocket Pharmaceuticals.
News SentimentNeutral | Hype SentimentBearish | Insider SentimentDisposing |
Rocket Historical Sentiment
Although Rocket Pharmaceuticals' investment sentiment alone cannot always predict changes in its future share prices, when combined with other fundamental and technical analysis, a better chance to time the market can be gained. Certain informational and emotional events regarding Rocket, such as negative comments on social media and news outlets, may cause fear in the market and push Rocket Pharmaceuticals' investors to sell their holdings. The opposite can also be true when favorable news is released; it may translate into optimism and boost the price of Rocket.
Rocket Pharmaceuticals Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards Rocket Pharmaceuticals can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Rocket Pharmaceuticals Historical Investor Sentiment
Investor biases related to Rocket Pharmaceuticals' public news can be used to forecast risks associated with an investment in Rocket. The trend in average sentiment can be used to explain how an investor holding Rocket can time the market purely based on public headlines and social activities around Rocket Pharmaceuticals. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Rocket Pharmaceuticals' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Rocket Pharmaceuticals and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average Rocket Pharmaceuticals news discussions. The higher the estimate score, the more favorable the investor's outlook on Rocket Pharmaceuticals.
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of Rocket Pharmaceuticals' Stock prices. Below is the latest headlines and news related to Rocket Pharmaceuticals Stock. Current markets are slightly bullish. About 55% of major world exchanges and indexes are currently up. See today's market update for more information.
There is far too much social signal, news, headlines, and media speculation about Rocket Pharmaceuticals that are available to investors today. This information is accessible both publicly - through Rocket Pharmaceuticals' media outlets and privately, via word of mouth or internal channels. However, regardless of the source, the sheer volume of Rocket-related data is difficult to distill into actionable insights, especially for investors who are not well-versed in the rapidly evolving tools and techniques of investment management.
A primary focus of Rocket Pharmaceuticals news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Rocket Pharmaceuticals relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Rocket Pharmaceuticals' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Rocket Pharmaceuticals alpha.
Rocket Largest EPS Surprises
Earnings surprises can significantly impact Rocket Pharmaceuticals' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2018-08-08 | 2018-06-30 | -0.36 | -0.4 | -0.04 | 11 | ||
2025-08-07 | 2025-06-30 | -0.5622 | -0.62 | -0.0578 | 10 | ||
2020-08-05 | 2020-06-30 | -0.51 | -0.45 | 0.06 | 11 | ||
2020-11-04 | 2020-09-30 | -0.46 | -0.53 | -0.07 | 15 | ||
2022-11-03 | 2022-09-30 | -0.79 | -0.87 | -0.08 | 10 | ||
2018-05-11 | 2018-03-31 | -0.33 | -0.42 | -0.09 | 27 |
There is far too much social signal, news, headlines, and media speculation about Rocket Pharmaceuticals that are available to investors today. This information is accessible both publicly - through Rocket Pharmaceuticals' media outlets and privately, via word of mouth or internal channels. However, regardless of the source, the sheer volume of Rocket-related data is difficult to distill into actionable insights, especially for investors who are not well-versed in the rapidly evolving tools and techniques of investment management.
A primary focus of Rocket Pharmaceuticals news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Rocket Pharmaceuticals relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Rocket Pharmaceuticals' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Rocket Pharmaceuticals alpha.
Rocket Pharmaceuticals Performance against Dow Jones
Price Growth (%) |
| Timeline |
1 | Trading Action Can Rocket Pharmaceuticals Inc expand into new markets - Entry Point Smart Money Movement Alerts - | 09/17/2025 |
2 | Insider Trading | 09/24/2025 |
3 | Possible Signal As Rocket Pharmaceuticals Insiders Sell US1.1m In Stock | 10/15/2025 |
4 | Is Rocket Pharmaceuticals Inc. stock attractive for passive investors - July 2025 PostEarnings Safe Entry Trade Reports - newser.com | 10/29/2025 |
5 | Acquisition by Wilson Martin of 100000 shares of Rocket Pharmaceuticals subject to Rule 16b-3 | 11/03/2025 |
6 | Is Rocket Pharmaceuticals Inc. Equity Warrant stock poised for growth - Weekly Earnings Recap Verified Short-Term Plans - newser.com | 11/05/2025 |
7 | Rocket Pharmaceuticals GAAP EPS of -0.45 beats by 0.05 | 11/06/2025 |
8 | Gainey McKenna Egleston Announces A Class Action Lawsuit Has Been Filed Against Rocket Pharmaceuticals, Inc. | 11/12/2025 |
9 | How Rocket Pharmaceuticals Inc. stock trades after rate cuts - Forecast Cut Daily Entry Point Trade Alerts - newser.com | 11/19/2025 |
10 | Rocket Pharmaceuticals to Participate in the 8th Annual Evercore Healthcare Conference | 11/25/2025 |
11 | Were Keeping An Eye On Rocket Pharmaceuticals Cash Burn Rate | 12/09/2025 |
Additional Tools for Rocket Stock Analysis
When running Rocket Pharmaceuticals' price analysis, check to measure Rocket Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Rocket Pharmaceuticals is operating at the current time. Most of Rocket Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Rocket Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Rocket Pharmaceuticals' price. Additionally, you may evaluate how the addition of Rocket Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.